Skip to content

Clinical trials

Phase 3 Hematologic Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 3 Country / region: Spain Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20111
20121
20161
20171
20181
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen1
Bristol-Myers Squibb1
CSL Behring1
Gamida Cell ltd1
Kiadis Pharma1
Kura Oncology, Inc.1
Lakefront Biotherapeutics NV1
Merck Sharp & Dohme LLC1
Quetzal Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms12
Leukemia4
Bone Marrow Diseases3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Leukemia, Myeloid, Acute3
Hematologic Diseases2
Leukemia, Myeloid2
Lymphoma2
Multiple Myeloma2
Myelodysplastic Syndromes2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.